Zhang Dan-Tong, Shi Guang-Xia, Jia Jin-Ying, Tan Feng-Wei, Qi Yu, Liang Wei, Zhao Zhi-Jun, Yuan Ping, Gao Ya, Zhang Guo-Chao, Liu Xue-Hui, Yang Jing-Wen, Wang Li-Qiong, Wang Xiao, Yang Na-Na, Tu Jian-Feng, Liu Cun-Zhi
International Acupuncture and Moxibustion Innovation Institute, School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
PLoS One. 2025 Mar 26;20(3):e0316698. doi: 10.1371/journal.pone.0316698. eCollection 2025.
Despite the use of multimodal analgesia regimens following video-assisted thoracoscopic surgery (VATS), acute postoperative pain persists. Electroacupuncture (EA) may alleviate acute postoperative pain following VATS; however, current evidence remains insufficient.
This trial will assess the feasibility and efficacy of EA as an adjunctive treatment compared with sham electroacupuncture (SA) for managing acute postoperative pain during coughing after VATS.
In this pilot randomized controlled trial, 60 patients with non-small-cell lung cancer who will undergo VATS will be randomly assigned to either the EA or SA group in a 1:1 ratio. Patients will receive standard care combined with four sessions of EA or SA within 72 h after surgery. The primary outcome will be the average postoperative pain score during coughing, measured using a numeric rating scale within 72 h after surgery. Secondary outcomes will include the average daily pain scores at rest, during coughing, and while mobilizing; incidence of chronic post-surgical pain; quality of life; cough symptom score; and analgesic consumption. All adverse events will be recorded in detail.
This study will determine whether EA as an adjunctive treatment can reduce acute postoperative pain during coughing following VATS.
ClinicalTrial.gov ITMCTR2024000170 (http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=f1a344f7-7e06-4665-ad9d-0917d588eba6).
尽管在电视辅助胸腔镜手术(VATS)后使用了多模式镇痛方案,但术后急性疼痛仍然存在。电针(EA)可能减轻VATS后的术后急性疼痛;然而,目前的证据仍然不足。
本试验将评估与假电针(SA)相比,EA作为辅助治疗在VATS后咳嗽时管理术后急性疼痛的可行性和有效性。
在这项前瞻性随机对照试验中,60例将接受VATS的非小细胞肺癌患者将按1:1的比例随机分配到EA组或SA组。患者将接受标准护理,并在术后72小时内接受4次EA或SA治疗。主要结局将是术后咳嗽期间的平均疼痛评分,采用术后72小时内的数字评分量表进行测量。次要结局将包括休息时、咳嗽时和活动时的平均每日疼痛评分;慢性术后疼痛的发生率;生活质量;咳嗽症状评分;以及镇痛药物的消耗量。所有不良事件都将详细记录。
本研究将确定EA作为辅助治疗是否能减轻VATS后咳嗽时的术后急性疼痛。
ClinicalTrial.gov ITMCTR2024000170(http://itmctr.ccebtcm.org.cn/zh-CN/Home/ProjectView?pid=f1a344f7-7e06-4665-ad9d-0917d588eba6)。